A genetic test to determine cancer risk in advance
Strand Hereditary Cancer Test
- What information does the Strand Hereditary Cancer Test provide?
The test provides information to identify and estimate risk for cancer predisposition.
- For whom should the Strand Hereditary Cancer Test be considered?
The test can be considered for identifying if the cancer is hereditary in affected individuals, or for risk estimation in unaffected family members, in any of these situations:
- Early onset of cancer
- A history of multiple cancers
- Multiple family members affected with cancer
- Rare cancers
- Turnaround Time
The test report is delivered 3-4 weeks from receipt of sample in the lab.
- Sample requirement (any one of the following)
Saliva in collection kits provided by Strand
Blood in EDTA tubes (2-5ml)
Dry blood spot (in kits provided by Strand)
Buccal swab (in kits provided by Strand)
DNA isolated from blood
- Test method
- MLPA for large deletions
Large deletions are confirmed by MLPA. Genes covered are BRCA1, BRCA2, MLH1/MSH2 (as one test), and RB1.
- Mutation specific testing
Mutation specific testing is offered to identify mutations in other family members once the mutation is confirmed in the proband.
Learn more about the Strand Hereditary Cancer Test
Download Strand Hereditary Cancer Test Brochure